tiprankstipranks
Trending News
More News >

Richard J. Daly Insider Profile

4 Followers
Richard J. Daly, President & CEO, Director at Catalyst Pharma, holds 271.27K shares in Catalyst Pharma (Ticker: CPRX), holds 0.00 shares in Opiant Pharmaceuticals (Ticker: OPNT), holds 31.25K shares in Palisade Bio (Ticker: PALI).
tipranks
Richard J. Daly

Richard J. Daly
Catalyst Pharma (CPRX)
President & CEO, Director

Ranked #101,067 out of 105,518 Corporate Insiders

Profitable Transactions

0%
0 out of 7 Profitable Transactions

Average Return

-59.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6M
99.04%
0.96%
A breakdown of Richard J. Daly's holdings

Insider Roles

Catalyst Pharma
(CPRX)
President & CEO, Director
Palisade Bio
(PALI)
CEO, Director
Roles that Richard J. Daly holds in companies

Most Profitable Insider Trade

Stock:
Palisade Bio
(PALI)
Rating:Informative Buy
Date:Jan 27, 2017 - Jan 27, 2018
Return:-38.00%
The most profitable trade made by Richard J. Daly

Richard J. Daly's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Catalyst Pharma
Jan 06, 2026
President & CEO, Director
Uninformative Buy
718.84K
$6.06M
Palisade Bio
May 18, 2017
CEO, Director
Informative Buy
30.00K
$59.06K
OPNT
Opiant Pharmaceuticals
Mar 03, 2023
Uninformative Sell
116.00K
$0.00
SGYPQ
Synergy Pharmaceuticals Inc
$0.00
List of latest transactions for each holding click on a transaction to see Richard J. Daly's performance on stock

Richard J. Daly insider profile FAQ

What is the percentage of profitable transactions made by Richard J. Daly?
The percentage of profitable transactions made by Richard J. Daly is 0%.
    What is the average return per transaction made by Richard J. Daly?
    The average return per transaction made by Richard J. Daly is -59.50%.
      What stocks does Richard J. Daly hold?
      Richard J. Daly holds: CPRX, PALI, OPNT, SGYPQ stocks.
        What was Richard J. Daly’s latest transaction?
        Richard J. Daly latest transaction was an Uninformative Buy of $718.84K.
          What was Richard J. Daly's most profitable transaction?
          Richard J. Daly’s most profitable transaction was an Informative Buy of PALI stock on January 27, 2017. The return on the trade was -38.00%.
            What is Richard J. Daly's role in Catalyst Pharma?
            Richard J. Daly's role in Catalyst Pharma is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.